GlaxoSmithKline faces new corruption allegations in Syria, where it has been accused of paying bribes to secure business.» Read More
July 1- Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.
European shares closed flat on Monday, at the start of a week packed with important economic data.
LONDON, June 29- GlaxoSmithKline on Sunday confirmed the existence of an intimate video recording of its former China head, Mark Reilly, which the Sunday Times reported kicked off a bribery investigation that has damaged the drugmaker's business in China.
*Novo Nordisk deputy CEO sees group growing 10 pct annually. COPENHAGEN, June 25- Danish drugmaker Novo Nordisk, the world's biggest insulin maker, expects to more than double its annual revenue within a decade, its deputy chief executive Kaare Schultz told Reuters.
WASHINGTON, June 24- A GlaxoSmithKline Plc plant in Canada that makes the flu vaccine Flulaval has been cited by the U.S. Food and Drug Administration for failing to meet quality control standards.
WASHINGTON, June 24- The U.S. Food and Drug Administration has warned GlaxoSmithKline Plc that one of its plants in Canada violated quality control standards during the manufacture of its influenza vaccine Flulaval.
June 24- The U.S. Food and Drug Administration said an unit of GlaxoSmithKline Plc violated quality requirements during the manufacture of influenza vaccine Flulaval. In a warning letter, the FDA said the company had failed to take appropriate steps to prevent microbiological contamination of drugs, among other violations.
MUMBAI, June 24- The government of India is likely to raise the number of drugs deemed essential and subject to price caps, people directly involved in the process said.
The new UK Dementias Research Platform will investigate the causes of dementia by tracking volunteers, aged 50 and over, who are taking part in existing population studies such as UK Biobank and the Million Women Study. Major pharmaceutical companies backing the initiative include AstraZeneca, GlaxoSmithKline and Johnson& Johnson.
PARIS, June 18- Japan's Ajinomoto Co may not have found a partner in French ingredients company Diana Group, but unlike the famous Paul Anka love song- a favourite of CEO Masatoshi Ito- the food company is moving on, and looking for other deals.
The red carpet was rolled out from Windsor to Downing Street for China, as a high-profile trade delegation arrives in the U.K.
Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.
SHANGHAI, June 13- China's crackdown on corruption in the pharmaceutical sector has frightened foreign executives so much that some fear they could be jailed and have asked their lawyers if they should leave the country for six months.
Some of the names on the move ahead of the open.
LONDON, June 12- Johnson& Johnson has linked up with ViiV Healthcare- a specialist HIV company majority-owned by GlaxoSmithKline- to develop a new AIDS medicine combining two drugs in a single tablet.
Some of Wednesday's midday movers:
A takeover bid that caused much consternation didn't even go through after AstraZeneca PLC said "no thanks" to Pfizer Inc. in April. The episode caused Eric Sappenfield, co-manager of the John Hancock Global Shareholder Yield Fund, to turn cautious on Pfizer, although he still owns some.
June 4- British drugmaker GlaxoSmithKline Plc has agreed to pay $105 million to settle allegations by 44 U.S. states and the District of Columbia that it promoted its medicines for unapproved uses, several states attorneys general announced on Wednesday.
North Carolina's attorney general says GlaxoSmithKline will pay 45 states $105 million to settle claims that it unlawfully marketed drugs.